There were cheers and applause on Wednesday in Johannesburg, South Africa, where the country’s first coronavirus vaccines were administered. South Africa’s national rollout began after a complicated and disappointing start. The country received over a million units of the AstraZeneca vaccine at the beginning of February. But then new research showed that the AstraZeneca shot has limited efficacy against the predominant coronavirus variant in South Africa.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?